Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07712783Recruiting
Randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Ondokuz Mayıs University. Primary endpoint: Cumulative equivalent morphine consumption at 24 hours. Started Jul 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07712783.